A phase I trial of caffeine to evaluate safety in infants with hypoxic-ischemic encephalopathy
Wesley Jackson(University of North Carolina at Chapel Hill), Matthew M. Laughon(University of North Carolina at Chapel Hill), Rachel G. Greenberg(Duke University), Daniel González(University of North Carolina at Chapel Hill), Yueh Z. Lee(University of North Carolina at Chapel Hill)
Cited by 10
Related Papers
The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach
|American Journal of Respiratory and Critical Care Medicine|2019|1.2k
Significance of Protein Binding in Pharmacokinetics and Pharmacodynamics
|Journal of Pharmaceutical Sciences|2009|337
A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study)
|Clinical Infectious Diseases|2020|232
Selection of Antiobesity Medications Based on Phenotypes Enhances Weight Loss: A Pragmatic Trial in an Obesity Clinic
|Obesity|2021|199
Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing
|Clinical Therapeutics|2016|170